References
- Gibson BE, Wheatley K, Hann IM, . Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005;19:2130–2138.
- Lie SO, Abrahamsson J, Clausen N, . Long-term results in children with AML: NOPHO-AML Study Group—report of three consecutive trials. Leukemia 2005;19:2090–2100.
- Smith FO, Alonzo TA, Gerbing RB, . Long-term results of children with acute myeloid leukemia: a report of three consecutive phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891. Leukemia 2005;19:2054–2062.
- Webb DK, Wheatley K, Harrison G, . Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party. Leukemia 1999;13:25–31.
- Kumar CC. Genetic abnormalities and challenges in the treatment of acute myeloid leukemia. Genes Cancer 2011;2:95–107.
- Hasle H, Alonzo TA, Auvrignon A, . Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood 2007;109:4641–4647.
- Lie SO, Abrahamsson J, Clausen N, . Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials. Br J Haematol 2003;122:217–225.
- Grimwade D, Hills RK. Independent prognostic factors for AML outcome. Hematology Am Soc Hematol Educ Program 2009:385–395.
- Borrow J, Stanton VP Jr, Andresen JM, . The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 1996;14:33–41.
- Mo J, Lampkin B, Perentesis J, . Translocation (8;18;16)(p11;q21;p13). A new variant of t(8;16)(p11;p13) in acute monoblastic leukemia: case report and review of the literature. Cancer Genet Cytogenet 2006;165:75–78.
- Becher R, Haas OA, Graeven U, . Translocation t(8;16) in acute monocytic leukemia. Cancer Genet Cytogenet 1988;34:265–271.
- Haferlach T, Kohlmann A, Klein HU, . AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Leukemia 2009;23:934–943.
- Schmidt HH, Strehl S, Thaler D, . RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications. Leukemia 2004;18:1115–1121.
- Crowley JA, Wang Y, Rapoport AP, . Detection of MOZ-CBP fusion in acute myeloid leukemia with 8;16 translocation. Leukemia 2005;19:2344–2345.
- Hanslip JI, Swansbury GJ, Pinkerton R, . The translocation t(8;16)(p11;p13) defines an AML subtype with distinct cytology and clinical features. Leuk Lymphoma 1992;6:479–486.